Package 72189-630-30

{"route": ["ORAL"], "spl_id": "3c6c3546-b4a4-1f0e-e063-6394a90a8c29", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["387c9c12-4735-1f9d-e063-6394a90a030c"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "20 TABLET in 1 BOTTLE (72189-630-20)", "package_ndc": "72189-630-20", "marketing_start_date": "20250626"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (72189-630-30)", "package_ndc": "72189-630-30", "marketing_start_date": "20250626"}], "brand_name": "Valacyclovir", "product_id": "72189-630_3c6c3546-b4a4-1f0e-e063-6394a90a8c29", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72189-630", "generic_name": "Valacyclovir", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20250626", "listing_expiration_date": "20261231"}